A detailed history of Triumph Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Triumph Capital Management holds 2,909 shares of JNJ stock, worth $421,950. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,909
Previous 6,419 54.68%
Holding current value
$421,950
Previous $1.01 Million 54.27%
% of portfolio
0.2%
Previous 0.45%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$155.22 - $162.74 $544,822 - $571,217
-3,510 Reduced 54.68%
2,909 $460,000
Q4 2023

Feb 05, 2024

BUY
$145.6 - $158.88 $104,540 - $114,075
718 Added 12.59%
6,419 $1.01 Million
Q3 2023

Oct 31, 2023

BUY
$155.75 - $174.48 $520,205 - $582,763
3,340 Added 141.47%
5,701 $887,000
Q2 2023

Aug 03, 2023

SELL
$154.35 - $166.11 $287,399 - $309,296
-1,862 Reduced 44.09%
2,361 $390,000
Q1 2023

May 08, 2023

BUY
$151.05 - $180.26 $316,600 - $377,824
2,096 Added 98.54%
4,223 $654,000
Q4 2022

Jan 31, 2023

BUY
$160.2 - $179.79 $28,195 - $31,643
176 Added 9.02%
2,127 $375,000
Q3 2022

Nov 01, 2022

BUY
$161.33 - $179.52 $2,903 - $3,231
18 Added 0.93%
1,951 $319,000
Q2 2022

Aug 02, 2022

BUY
$168.19 - $186.01 $1,850 - $2,046
11 Added 0.57%
1,933 $343,000
Q1 2022

May 03, 2022

SELL
$158.14 - $179.59 $57,562 - $65,370
-364 Reduced 15.92%
1,922 $341,000
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $105,720 - $117,300
678 Added 42.16%
2,286 $391,000
Q3 2021

Nov 16, 2021

SELL
$161.5 - $179.47 $181,849 - $202,083
-1,126 Reduced 41.19%
1,608 $260,000
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $210,273 - $233,669
1,302 Added 90.92%
2,734 $407,000
Q2 2021

Jul 19, 2021

BUY
$159.48 - $171.07 $228,375 - $244,972
1,432 New
1,432 $244,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $379B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Triumph Capital Management Portfolio

Follow Triumph Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Triumph Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Triumph Capital Management with notifications on news.